Drotaverine is considered as an inhibitor of cyclic-3′,5′-nucleotide-phophodiesterase (PDE) enzymes. However, published receptor binding data supports the potential Ltype Voltage Operated Calcium Channel (L-VOCC) blocking effect of drotaverine too.
contraction. It was found that drotaverine, like the L-VOCC blockers nifedipine or diltiazem, inhibited the KCl-induced inward Ca 2+ -induced contraction in a concentration dependent fashion. The PDE-inhibitor theophylline had no effect on the KCl-evoked contractions indicating its lack of inhibition on inward Ca 2+ flow. show that drotaverine behaves like L-VOCC blockers but unlike PDE inhibitors using L-VOCC associated in vitro experimental models.
Introduction
Two families of drugs which inhibit PDE activity, methylxanthines and isoquinolines, are used clinically in 2 distinct therapeutic areas involving smooth muscle function.
Methylxanthines, such as theophylline, are frontline asthma medications, while the isoquinolines, like papaverine, are used to ameliorate the symptoms of visceral smooth muscle spasm and associated pain. However, neither of them are active if used in the opposite field -why is that? Based on indirect experimental evidence the difference may be associated with their differing activity on the voltage operated calcium channel (L-VOCC).
The natural isoquinoline alkaloide of Papaver sumniferrum, papaverine and its synthetic derivate drotaverine have been broadly used as antispasmodic agents in human medicine for decades. It has been published that drotaverine binds to the L-VOCC on pregnant rat uterine membranes (Tömösközi et al., 2002) while Ca 2+ activated potassium channels and L-VOCCs may be involved in papaverine-induced vascular relaxation in rat basilar artery (Han et al., 2007) . Moreover, it was shown that both molecules inhibit cyclic-3′,5′-nucleotide-phophodiesterase (PDE) enzymes with concentration dependent specificity (Kukovetz and Pöch,1970; Triner et al.,1970; Pöch and Kukovetz, 1971; Kukovetz et al., 1976 , Ji-Qun et al., 1995 .
However, the detailed molecular mechanism of action and associated function of drotaverine on airway smooth muscle has not yet been systematically investigated.
Especially, the interaction of drotaverine with the Ca 2+ flux essential for the contraction-relaxation machinery of airway smooth muscle has not been tested. Both of these cellular mechanisms play a fundamental regulatory role in smooth muscle function. In airway smooth muscle, bronchodilatory agents increase the intracellular This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on October 13, 2016 as DOI: 10.1124 at ASPET Journals on January 9, 2017 jpet.aspetjournals.org Downloaded from JPET#237271 5 cAMP level (e.g. by the inhibition of the PDEs) and cause the relaxation of precontracted (post-agonist administration) preparations (Torphy and Undem, 1991; Frossard et al., 1981) . However, these agents are less effective in the inhibition of the agonist-induced contraction (pre-agonist administration) (Bilcíková et al., 1987) . The airway smooth muscle contractile mechanism is considered to be triggered either by release of intracellularly sequestered Ca 2+ or by the increased influx of extracellular Ca 2+
. In airway smooth muscle the Ca 2+ release from the intracellular stores predominates over inward Ca 2+ flux through L-VOCCs after receptor activationinduced airway smooth muscle contraction (Pelaia G et al., 2008) . While operation of L-VOCCs can induce some relaxation of agonist-induced pre-contracted airway smooth muscle (Fanta et al., 1982) they are not effective prior to agonist administration (Foster et al., 1984) . This may explain why L-VOCC blockers have no principal therapeutic benefit for the treatment of bronchial asthma (Hirota et al., 2003) . Airway smooth muscle receptor mediated activation uses intracelleluar Ca 2+ stores, whereas vascular smooth muscle is more dependant on Ca 2+ influx.
However, the L-VOCCs may play a role in the Ca 2+ balance necessary for the maintenance of the physiological airway smooth muscle function. In this context the principal role of L-VOCCs may be the regulation of the Ca 2+ influx responsible for refilling of the intracellular Ca 2+ stores that are partly depleted during agonist-induced contraction in airway smooth muscle (Bourreau et al., 1993) . It has been demonstrated that L-VOCC blockers are able to inhibit the refill of the depleted sarcoplasmatic Ca 2+ stores in resting conditions (Bourreau et al., 1991; Liu and Farley, 1996) , while their impact on receptor activation associated inward Ca 2+ currents and subsequent contractions in normal Ca 2+ containing medium is minimal (Cheng and Townley, 1983) . We have hypothesized that the L-VOCCs may also play . Our aim with this study was to generate functional data supporting the potential L-VOCC blocking effect of drotaverine using proven L-VOCC dependent tracheal models (e.g. KCl depolarisation induced contractions (Foster et al., 1983) , resting Ca 2+ -refill linked contractions and receptor mediatedinward Ca 2+ -induced contractions). 
Methods

Chemicals
Isolation of the trachea, and organ bath preparation
On the day of the experiments the guinea-pigs were euthanized by an overdose of pentobarbital sodium. The trachea was rapidly removed and placed in KrebsHenseleit (KH) solution of the following composition (mM): NaCl-119, NaHCO 3 -25.0, CaCl 2 -2.5, KCl-4.7, KH 2 PO 4 -1.2, MgSO 4 -1.2, glucose-11.1, 5·10 -6 M indomethacin.
The cartilaginous rings from the distal part of the trachea were opened longitudinally and mounted in a 20 ml organ bath containing KH solution, maintained at 37.4 o C, and continuously bubbled with 95 % O 2 and 5 % CO 2 to give a pH of 7.4 ± 0.1. The preparations were preloaded with 5 millinewton (mN; approx. 0.5 g). The tissues were then allowed to equilibrate for at least 1 hour, during which time they were washed approximately every 20 min with fresh KH solution. Eight tracheal strip preparations were used from the same guinea pigs on the same day. Four preparations were used for the control groups while the other four preparations were used for the test compounds. Earlier studies showed no difference in reactivity to histamine or methacholine with respect to tracheal ring location from this part of the trachea (data not shown).
The strength of the isometric contractile responses was measured (mN) using a force displacement transducer and preamplifier (MDE Co.
Ltd., Budapest, Hungary). The experimental data were collected and evaluated by a computer aided data acquisition system (SpelIso v3.2 software; MDE Co. Ltd., Budapest, Hungary).
Due to small variations in the baselines and the acclimation of the tissue preparations to the organ bath environment, the second contraction force was in many cases The intracellular Ca 2+ dependent contractions were tested using two mediators that induce contraction of airway smooth muscle, histamine (3x10 -6 M) and methacholine (5x10 -7 M). The concentrations chosen were the calculated EC 50 values for these mediators from previous experiments in our laboratory (data not shown).
Histamine and methacholine were used in separate experiments. Following the This article has not been copyedited and formatted. The final version may differ from this version. after which three consecutive contractions were evoked by constrictor agonists, each separated by a wash out period. The contraction force was measured (mN) and the percentage contraction values were calculated using the second agonist-induced contraction as 100 % contraction. The experimental design is shown in Figure 1B .
CaCl 2 -induced contraction in agonist containing Ca 2+ free medium (receptor operated refill)
The experimental protocol was indentical with the "resting refill" protocol up to the intracellular Ca 2+ depletion step in Ca 2+ free medium. As before, the third agonist stimulation evoked only limited if any contraction denoting the depleted Ca 2+ content of the intracellular calcium stores ( Figure 1C . In this experimental protocol both the maximum contraction and the slope of the contractions were evaluated. The percentage decrease of the contraction force was also calculated.
Statistics
Statistical comparison of the treated versus non-treated (control) groups was conducted by using Student's t-test (GraphPad Prism v6.0, La Jolla, CA). Differences among groups were considered statistically significant when the P value was <0.05.
Results
KCl depolarisation
KCl caused contraction of the guinea pig tracheal preparation in a concentration dependent fashion. The contraction force generated by 20 mM, 30 mM and 50 mM was 4.0 ± 2.2, 9.5 ± 2.5 and 13.9 ± 3.1 mN (n=122), respectively. The KCl responses were reproducible in control preparations each time they were repeated for constructing drug dose-response curves (data not shown). L-VOCC blockers e.g. Table 1 ). Unlike the L-VOCC blockers, the PDE inhibitor theophylline did not modify the KCl-induced contractions indicating that the cAMP/PDE system doesn't play a significant role. The mixture of the equimolar concentrations of nifedipine and theophylline behaved more like an L-VOCC blockers alone in this experimental mode ( Figure 2 , Table 1 ). Interestingly, the inhibitory efficacy of the nifedipine and theophylline combination was significantly higher than that of nifedipine alone. This observation will be explored in future studies.
Ca
2+ reload followed agonist-induced contractions in Ca 2+ free medium (resting refill)
Both 3x10 -6 M histamine and 5x10 -7 M methacholine in normal KH solution induced tracheal smooth muscle contractions of similar strength (11.9 ± 3.2 mN n=43 and 10.4 ± 2.8 mN n=32, respectively). With consecutive administration of histamine and methacholine, the contraction force decreased gradually in calcium free KH medium to 70.7 ± 14.8%, 22.9 ± 25.1% and 3.0 ± 6.3% (n=43) and 76.2 ± 12.4%, 13.3 ± 16.8% and 0.4 ± 1.1% (n=32), respectively of the original reference contraction (Table 2A and 2B) . Following agonist-provoked calcium depletion the preparations were put into normal KH solution (reload solution) and incubated for 30 min in order to let the depleted calcium stores refill (resting refill). The organ bath solution was replaced with a calcium free medium (post-reload), after which the preparations were able to contract again with agonist stimulation, indicating refilling of their intracellular calcium stores (Table 2A and Table 2B, L-VOCC blockers may inhibit the resting Ca 2+ refill of emptied intracellular calcium stores regardless of the constrictor mediator used ( Table 2 ).
The non-specific phosphodiesterase inhibitor theophylline was also tested on the resting calcium refill model. However, as can be seen in Figure 4E , theophylline, unlike L-VOCC blockers enhanced, rather than inhibited the histamine-induced contraction. The combination of 10 -5 M theophylline with 10 -5 M nifedipine in the Ca 2+ refill medium inhibited the agonist-induced contraction in the post-reload calcium free medium ( Figure 3F and Figure 4F ).
Drotaverine and papaverine were also tested on this model ( Figure 3A , 4A and Figure 3B , 4B). Both drotaverine and papaverine blocked the resting Ca 2+ refill associated contractions at 10 -5 M concentration, making these two isoquinoline derivatives more similar to the L-VOCC blockers than to the PDE inhibitors. ) KH solution at the start of the experimental protocol. Neither the maximal contraction force, nor the slope (Table 3) of the contraction of the control preparations differed markedly between the two experimental conditions. So the mechanical response to the agonist-induced contraction in normal KH solution is identical with the contraction developed by adding CaCl 2 to the Ca 2+ free KH solution containing the agonist. The L-VOCC blockers, nifedipine or diltiazem (10 -5 M), decreased the slope of the CaCl 2 -induced contraction force. This effect was not agonist specific (Table 3) , as they blunted the force development slope in the presence of both histamine and methacholine.
In the same model, both drotaverine and papaverine decreased the slope of the CaCl 2 -induced contraction (Table 4) , and in this context the two tested isoquinoline derivatives behaved like the L-VOCC blockers. However, the PDE inhibitor theophylline had no effect on the contraction slope with either agonist in the organ Traditional L-VOCC blockers and papaverine are able to inhibit the KCl-induced contraction through the inhibition of depolarisation triggered inward calcium current (Cheng and Townley, 1983; Cerrina et al., 1983; Foster et al., 1984; Baersch and Frölich, 1995; Ohashi M and Takayanagi, 1983) . Our results showed that both papaverine and drotaverine but not theophylline inhibited the KCl-induced contractions in a dose-dependent fashion. Others (Small et al., 1989) supported by the relative ineffectiveness of L-VOCC blockers on agonist-induced tracheal contractions described by others (Drazen et al., 1983; Advenier et al., 1984; Ahmed et al., 1985; Baersch and Frölich, 1995 (Creese and Denborough, 1981; Noguera et al., 1994) . If the Ca 2+ depleted preparation is then transferred to a normal Ca 2+ containing buffer, the intracellular Ca 2+ stores are refilled (Noguera et al., 1995) . It is highly probable that inward Ca 2+ flux through the L-VOCC is the main mechanism for the post contraction Ca 2+ refill (Bourreau et al., 1991; Bourreau et al., 1993; Dessy and Godfraind, 1996; Hirota and Janssen, 2007; Flores-Soto et al., 2013 containing KH buffer (reload medium), the agonists were again able to evoke contraction in the post-reload Ca 2+ free medium. The observed reaction was mediator independent since both the mast cell mediator histamine, and the muscarinic M 3 receptor agonist methacholine, produced the same result. Similarly to the L-VOCC blockers (e.g.nifedipine or diltiazem), isoquinolines introduced to the Ca 2+ reload medium inhibited the histamine or methacholine-induced contraction in the post reload Ca 2+ free solution suggesting that the observed mechanism is linked to L-VOCC function. In contrast, using the PDE inhibitor theophylline in the Ca 2+ reload medium, did not block, and rather increased the magnitude of the constrictor entry, and other channels allow a slower entry. The PDE inhibitor, theophylline, had no effect on either the contraction slope or on the magnitude of contraction, indicating that the mechanism is independent of the cAMP/PDE system. This hypothesis is further supported by the result that mixed equimolar concentrations of nifedipine and theophylline behaved more like L-VOCC blockers.
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